Literature DB >> 35927524

Presentation and clinical course of pediatric-onset versus adult-onset Takayasu arteritis-a systematic review and meta-analysis.

Durga Prasanna Misra1, Upendra Rathore2, Chirag Rajkumar Kopp3, Pallavi Patro4, Vikas Agarwal2, Aman Sharma3.   

Abstract

Takayasu arteritis (TAK) is a less common large-vessel vasculitis which can occur in either children or adults. However, differences between pediatric-onset and adult-onset TAK have not been systematically analyzed. We undertook a systematic review (pre-registered on PROSPERO, identifier CRD42022300238) to analyze differences in clinical presentation, angiographic involvement, treatments, and outcomes between pediatric-onset and adult-onset TAK. We searched PubMed (MEDLINE and PubMed Central), Scopus, major recent international rheumatology conference abstracts, Cochrane database, and clinicaltrials.gov, and identified seven studies of moderate to high quality comparing pediatric-onset and adult-onset TAK. Meta-analysis of 263 pediatric-onset and 981 adult-onset TAK suggested that constitutional features (fever, and in subgroup analyses, weight loss), hypertension, headache, and sinister features of cardiomyopathy, elevated serum creatinine, and abdominal pain were more frequent in pediatric-onset TAK, whereas pulse loss/pulse deficit and claudication (particularly upper limb claudication) were more frequent in adult-onset TAK. Hata's type IV TAK was more common in pediatric-onset TAK, and Hata's type I TAK in adult-onset TAK. Children with TAK also appeared to require more intense immunosuppression with more frequent use of cyclophosphamide, biologic DMARDs, tumor necrosis factor alpha inhibitors, and, in subgroup analyses, tocilizumab in pediatric-onset TAK than in adult-onset TAK. Surgical or endovascular procedures, remission, and risk of mortality were similar in both children and adults with TAK. No studies had compared patient-reported outcome measures between pediatric-onset and adult-onset TAK. Distinct clinical features and angiographic extent prevail between pediatric-onset and adult-onset TAK. Clinical outcomes in these subgroups require further study in multicentric cohorts.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Aortitis syndrome; Childhood onset; Large-vessel vasculitis; Pediatric onset; Pediatric vasculitis; Takayasu arteritis

Year:  2022        PMID: 35927524     DOI: 10.1007/s10067-022-06318-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  42 in total

1.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

Review 2.  Diagnostic criteria for Takayasu arteritis.

Authors:  B K Sharma; S Jain; S Suri; F Numano
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

3.  Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy.

Authors:  K Ishikawa
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

Review 4.  Recent advances in the management of Takayasu arteritis.

Authors:  Durga Prasanna Misra; Anupam Wakhlu; Vikas Agarwal; Debashish Danda
Journal:  Int J Rheum Dis       Date:  2019-01       Impact factor: 2.454

Review 5.  Pathogenesis of Takayasu's arteritis: a 2011 update.

Authors:  Laurent Arnaud; Julien Haroche; Alexis Mathian; Guy Gorochov; Zahir Amoura
Journal:  Autoimmun Rev       Date:  2011-08-09       Impact factor: 9.754

6.  EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.

Authors:  Seza Ozen; Angela Pistorio; Silvia M Iusan; Aysin Bakkaloglu; Troels Herlin; Riva Brik; Antonella Buoncompagni; Calin Lazar; Ilmay Bilge; Yosef Uziel; Donato Rigante; Luca Cantarini; Maria Odete Hilario; Clovis A Silva; Mauricio Alegria; Ximena Norambuena; Alexandre Belot; Yackov Berkun; Amparo Ibanez Estrella; Alma Nunzia Olivieri; Maria Giannina Alpigiani; Ingrida Rumba; Flavio Sztajnbok; Lana Tambic-Bukovac; Luciana Breda; Sulaiman Al-Mayouf; Dimitrina Mihaylova; Vyacheslav Chasnyk; Claudia Sengler; Maria Klein-Gitelman; Djamal Djeddi; Laura Nuno; Chris Pruunsild; Jurgen Brunner; Anuela Kondi; Karaman Pagava; Silvia Pederzoli; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2010-05       Impact factor: 19.103

Review 7.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

Review 8.  Childhood-onset Takayasu arteritis: an update.

Authors:  Ashish J Mathew; Ruchika Goel; Sathish Kumar; Debashish Danda
Journal:  Int J Rheum Dis       Date:  2015-11-20       Impact factor: 2.454

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

10.  Novel Th17 Lymphocyte Populations, Th17.1 and PD1+Th17, are Increased in Takayasu Arteritis, and Both Th17 and Th17.1 Sub-Populations Associate with Active Disease.

Authors:  Kritika Singh; Upendra Rathore; Mohit Kumar Rai; Manas R Behera; Neeraj Jain; Manish Ora; Dharmendra Bhadauria; Supriya Sharma; Gaurav Pande; Sanjay Gambhir; Alok Nath; Sudeep Kumar; Aman Sharma; Vikas Agarwal; Durga Prasanna Misra
Journal:  J Inflamm Res       Date:  2022-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.